QuotedData

Quoted Data

sign up for emailed equity research
Quick  |   Customised Register
Latest News

Biotech and Healthcare News

Biotech Growth notches up small rise in Jan, but outlook for Feb is weaker

Biotech Growth notches up small rise in Jan, but outlook for Feb is weaker

Biotech Growth notches up small rise in Jan, but outlook for Feb is weaker Orbimed-managed Biotech Growth Trust (BIOG) notched up a broadly in-line performance in the otherwise strong month of January, ...

Trust favourite Biogen hit by AD trial rejig

Trust favourite Biogen hit by AD trial rejig

Trust favourite Biogen hit by AD trial rejig - Shares in Biogen, the neurology-focused US biotech giant and a key holding for many of the sector specialist investment trusts, fell ...

HBM Healthcare reaps $28m profit on sale of TandemLife stake

HBM Healthcare reaps $28m profit on sale of TandemLife stake

HBM Healthcare reaps $28m profit on sale of TandemLife stake Swiss-listed HBM Healthcare Investments (HBMN.S) should realise an profit of at least $27.6m on the sale of its holding in the ...

IBT key beneficiary of massive BMS-Nektar deal

IBT key beneficiary of massive BMS-Nektar deal

IBT key beneficiary of massive BMS-Nektar deal - International Biotech Trust (IBT) looks set to be the main investment trust beneficiary of the massive deal signed today between Bristol-Myers Squibb (BMS) and ...

BBH's first annual report delivers positive news

BBH’s first annual report delivers positive news

BBH's first annual report delivers positive news- BBH has announced results for the year ended 30 November 2017, over the period the  total return was 19.3%, an outperformance of 4.9% versus the ...

Key trust holding Vertex gains US approval for new CF combo

Key trust holding Vertex gains US approval for new CF combo

Key trust holding Vertex gains US approval for new CF combo Vertex Pharmaceuticals, a leading US biotech specialising in cystic fibrosis (CF) and core holding for most of the sector's collective investment ...

Swiss biotech trusts resilient after recent sell-off

Swiss biotech trusts resilient after recent sell-off

Swiss biotech trusts resilient after recent sell-off - Swiss-listed biotech investment trusts, HBM Healthcare Investments (HBMN.S) and BB Biotech (BBB.S), have fared by far the best among all the sector specialist closed-end collective ...

BioPharma Credit makes $150m loan to NovoCure

BioPharma Credit makes $150m loan to NovoCure

BioPharma Credit makes $150m loan to NovoCure - BioPharma Credit has entered into a definitive term senior secured loan agreement for US$150 million with NovoCure Limited (NASDAQ: NVCR), a commercial stage ...

BB Biotech tops biotech trust league in January

BB Biotech tops biotech trust league in January

BB Biotech tops biotech trust league in January Swiss-listed BB Biotech (BBB), managed by Bellevue Asset Management, was the best performing biotech-specialist investment trust in January, achieving a 4.8% rise in ...

Contrasting movements likely for Biotech Growth Trust investees

Contrasting movements likely for Biotech Growth Trust investees

Contrasting movements likely for Biotech Growth Trust investees Orbimed-managed Biotech Growth Trust (BIOG) looks set to see some contrasting fortunes for key investments in its January update, due in the middle of ...

Contact us

captcha